表紙
市場調査レポート

世界のインスリンデリバリーシステム市場の予測

Insulin Delivery Systems Market Forecast to 2014

発行 RNCOS E-Services Pvt. Ltd. 商品コード 231238
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
世界のインスリンデリバリーシステム市場の予測 Insulin Delivery Systems Market Forecast to 2014
出版日: 2012年02月01日 ページ情報: 英文 90 Pages
概要

現在、世界各国で糖尿病患者数が増加しており、2030年には5億5200万人に達する、と予想されています。この動きに対応して、糖尿病治療用の医療器具(各種のインスリン注入用装置)の市場も拡大しており、また新しい治療装置の開発・市場投入も進められています。全世界のインスリンデリバリー装置の市場は、2012〜2014年に年平均(CAGR)8%の成長を遂げると推計されています。

当レポートでは、全世界のインスリン放出用装置の技術・市場動向について調査し、糖尿病の蔓延状況や市場促進要因、全世界および各国での市場動向、個別製品の詳細、新製品の開発動向、主要企業プロファイルなどの情報を盛り込み、概略以下の構成でお届けします。

第1章 アナリストの見解

第2章 分析手法

第3章 世界の糖尿病治療薬市場の概況

第4章 主な市場促進要因

第5章 世界のインスリンデリバリー装置市場の概要

  • インド
    • 有病率
    • 市場分析
  • 中国
    • 有病率
    • 市場分析
  • 米国
    • 有病率
    • 市場分析
  • ロシア
    • 有病率
    • 市場分析
  • ブラジル
    • 有病率
    • 市場分析

第6章 インスリンデリバリー装置

  • インスリンペン
    • メカニズムと技術
    • 賛成・反対意見
    • 市場分析
    • 主な企業・製品
  • インスリンポンプ
    • メカニズムと技術
    • 賛成・反対意見
    • 市場分析
    • 主な企業・製品
  • インスリンシリンジ
    • メカニズムと技術
    • 賛成・反対意見
    • 市場分析
    • 主な企業・製品
  • インスリンジェットインジェクター
    • メカニズムと技術
    • 賛成・反対意見
    • 市場分析
    • 主な企業・製品

第7章 新規開発された装置

  • 埋め込み型インスリンポンプ
  • インスリン吸入器
  • インスリンの口径投与/インスリンピル
  • ワクチン
  • MEMS技術
  • ランゲルハウス島細胞の移植
  • インスリンパッチ
  • インスリンパッチポンプ

第8章 主要企業

  • Novo Nordisk
  • Eli Lilly
  • Medtronic
  • Becton Dickinson
  • Sanofi Aventis
  • F. Hoffmann La Roche

図表一覧

目次

The global medical fraternity is alarmed at the rate at which the diabetic population has been increasing worldwide. It is expected that the number of diabetic patients in the world will reach around 552 Million by 2030. With such startlingly constant growth, the demand for diabetes solutions is increasing exceptionally across the globe and has cascading effects on testing equipment and delivery devices market. According to our latest research report, the insulin delivery system market is currently characterized by the emergence of new drug delivery devices, and this trend is likely to continue in the coming few years.

Our recent research “Insulin Delivery Systems Market Forecast to 2014”, states that manufacturers and service providers are recognizing and catering to the special needs of diabetics. As per our estimations, the global insulin delivery systems market will grow at a CAGR of around 8% during 2012-2014. The insulin delivery systems include insulin syringes, pens, pumps and jet injectors. According to our study, insulin syringes and pens dominate the global insulin delivery systems market. Besides, market penetration of both insulin pumps and needle-free injection jets is also rising due to technological advances.

On analyzing the recent trends and studying the latest developments, we found that a number of new insulin delivery systems will enter the market this year (2012), and these launches will open up new avenues of growth in the sector. Implantable insulin pumps, insulin inhalers and Insulin pump patches are among the emerging devices in the insulin delivery system market. The geographic segmentation analysis carried out in the research revealed how and to what extent the insulin delivery system market is growing in countries like India, China, and the US, among others.

A brief overview of traditional delivery devices and new & emerging technological products has been included in the study to present a balanced outlook of the industry. With a view to understanding the competitive landscape, we also studied and included profiles of key market players in the report. Overall, we have tried to include each and every significant detail relating to the global insulin delivery systems market in our comprehensive research in order to make it understandable to clients who are eyeing opportunities in the segment.

Table of Contents

1. Analyst View

2. Research Methodology

3. Global Diabetes Drug Market Overview

4. Key Market Drivers

5. Global Insulin Delivery Devices Market Overview

  • 5.1. India
    • 5.1.1. Prevalence
    • 5.1.2. Market Analysis
  • 5.2. China
    • 5.2.1. Prevalence
    • 5.2.2. Market Analysis
  • 5.3. US
    • 5.3.1. Prevalence
    • 5.3.2. Market Analysis
  • 5.4. Russia
    • 5.4.1. Prevalence
    • 5.4.2. Market Analysis
  • 5.5. Brazil
    • 5.5.1. Prevalence
    • 5.5.2. Market Analysis

6. Insulin Delivery Devices

  • 6.1. Insulin Pens
    • 6.1.1. Mechanism and Technologies
    • 6.1.2. Pros and Cons
    • 6.1.3. Market Analysis
    • 6.1.4. Key Players and Products
  • 6.2. Insulin Pumps
    • 6.2.1. Mechanism and Technologies
    • 6.2.2. Pros and Cons
    • 6.2.3. Market Analysis
    • 6.2.4. Key Players and Products
  • 6.3. Insulin Syringes
    • 6.3.1. Mechanism and Technologies
    • 6.3.2. Pros and Cons
    • 6.3.3. Market Analysis
    • 6.3.4. Key Players and Products
  • 6.4. Insulin Jet Injectors
    • 6.4.1. Mechanism and Technologies
    • 6.4.2. Pros and Cons
    • 6.4.3. Market Analysis
    • 6.4.4. Key Players and Products

7. Emerging Devices

  • 7.1. Implantable Insulin Pumps
  • 7.2. Insulin Inhalers
  • 7.3. Oral Insulin/Insulin Pill
  • 7.4. Vaccines
  • 7.5. MEMS Technology
  • 7.6. Islet Cell Transplantation
  • 7.7. Insulin Patch
  • 7.8. Insulin Patch Pump

8. Key Players

  • 8.1. Novo Nordisk
  • 8.2. Eli Lilly
  • 8.3. Medtronic
  • 8.4. Becton Dickinson
  • 8.5. Sanofi Aventis
  • 8.6. F. Hoffmann La Roche

List of Figures:

  • Figure 3-1: Global - Number of Diabetic Patients (Million), 2011 & 2030
  • Figure 3-2: Global - Healthcare Expenditure on Diabetes (Billion US$), 2011 & 2030
  • Figure 5-1: Global - Insulin Delivery Devices Market (Billion US$), 2010-2014
  • Figure 5-2: India - Insulin Market (Million US$), 2010 & 2015
  • Figure 5-3: India - Share of Key Players in Insulin Market (2010)
  • Figure 5-4: China - Insulin Syringes Market (Million US$), 2010-2014
  • Figure 5-5: China - Insulin Pump Market (Million US$), 2010-2014
  • Figure 5-6: China - Insulin Pen Market (Million US$), 2010-2014
  • Figure 5-7: China - Share of Key Players in Modern Insulin Market (2010)
  • Figure 5-8: US - Insulin Pumps Market (Million US$), 2010-2014
  • Figure 5-9: US - Insulin Pen Market (Million US$), 2010-2014
  • Figure 5-10: US - Insulin Syringes Market (Million US$), 2010-2014
  • Figure 5-11: US - Insulin Jet Injectors Market (Million US$), 2010-2014
  • Figure 5-12: US - Share of Key Players in Modern Insulin Market (2010)
  • Figure 5-13: Russia - Insulin Market (Million US$), 2010-2014
  • Figure 5-14: Russia - Share of Key Players in Insulin Market (2010)
  • Figure 5-15: Brazil - Insulin Market (Million US$), 2010-2014
  • Figure 5-16: Brazil - Share of Novo Nordisk in Insulin Market (2010)
  • Figure 6-1: Global - Insulin Pen Market (Billion US$), 2010-2014
  • Figure 6-2: Global - Insulin Pen Market by Region (%), 2011
  • Figure 6-3: Global - Insulin Pump Market (Billion US$), 2010-2014
  • Figure 6-4: Global - Share of Medtronic in Insulin Pumps Market (2010)
  • Figure 6-5: Global - Insulin Syringes Market (Billion US$), 2010-2014
  • Figure 6-6: Global - Insulin Jet Injectors Market (Million US$), 2010-2014

List of Tables:

  • Table 3-1: Global - Diabetic Population of Top 10 Countries (Million), 2011 & 2030
  • Table 5-1: India - Diabetic Patients in Age Group 20-79 Years (‘000), 2011 & 2030
  • Table 5-2: China - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
  • Table 5-3: US - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
  • Table 5-4: Russia - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
  • Table 5-5: Brazil - Diabetic Patients in Age Group 20-79 Years ('000), 2011 & 2030
  • Table 6-1: Global - Share of Players in Prefilled Insulin Pen Market (2010)
  • Table 6-2: Global - Key Insulin Pen Products by Company
  • Table 6-3: Global - Key Insulin Syringes Product by Manufacturer
Back to Top